Edison Investment Research is terminating coverage on Biodexa Pharmaceuticals (BDRX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Healthcare |
Update
Healthcare |
Update
Healthcare |
Flash note
Healthcare |
Flash note